Related Experiment Videos
Autoantibodies in scleroderma and tightskin mice
1Mount Sinai Medical Center, New York.
Current Opinion in Immunology
|December 1, 1994
Summary
Scleroderma in humans may stem from immune system defects. Studies in tightskin mice show this condition links to autoimmunity and autoantibodies targeting specific antigens.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Scleroderma is a complex autoimmune disease with a suspected immune system origin.
- The tightskin (Tsk) mouse model shares features with human scleroderma, offering insights into pathogenesis.
Purpose of the Study:
- To investigate the link between the scleroderma syndrome and autoimmunity in tightskin mice.
- To explore the role of autoantibodies in the context of scleroderma pathogenesis.
Main Methods:
- Utilized the tightskin mouse model to study scleroderma-like symptoms.
- Analyzed the presence and characteristics of autoantibodies in affected mice.
Main Results:
- The scleroderma syndrome in tightskin mice is associated with significant autoimmune activity.
- Specific autoantibodies were identified, interacting with known scleroderma target antigens.
Conclusions:
- The tightskin mouse model supports the hypothesis that scleroderma involves fundamental immune system dysregulation.
- Autoantibody production against specific antigens is a key feature of the scleroderma phenotype in this model.